Tower Research Capital (TRC)’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Tower Research Capital (TRC)’s Portfolio RXDX Stock Details RXDX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$143K	Buy
2022 Q4	$29K	Sell
2022 Q3	$291K	Buy
2022 Q2	$29K	Sell
2022 Q1	$59K	Buy
2021 Q4	$18K	Buy
2021 Q3	$10K	Sell
2021 Q2	$25K	Buy